ESR1 and breast carcinoma: Tamoxifen is used for the treatment of both early and advanced estrogen receptor-positive (ER+) breast cancer [65] and presently is the most sold drug, even as a generic drug in some countries, against this cancer type, but its use suffers from contraindications and serious adverse side effects.